Aayush Chaulagain

Aayush Chaulagain

Auto-generated profile, based on publicly available information

Aayush Chaulagain

Department of Medicine, Patan Academy of Health Sciences, Lalitpur, Nepal

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2025 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
ISIqra Shahid
Iqra Shahid
HAHadia Ahmad
Hadia Ahmad
SASaad Ashraf
Saad Ashraf
QMQasim Mehmood
Qasim Mehmood
AIAzka Ijaz
Azka Ijaz
ACAayush Chaulagain
Aayush Chaulagain
Introduction: Peripheral circulatory complication (PCC), a significant complication of type 2 diabetes mellitus (T2DM), poses a considerable mortality burden in the United States. This study aimed to analyse demographic and geographic disparities in PCC‐related mortality in T2DM patients from 1999 to 2020. Methods: Utilising the CDC WONDER database, we utilised death certificates to identify PCC‐related deaths using ICD‐10 Code E11.5 and calculated age‐adjusted mortality rates (AAMRs) per 1,000,000 individuals. Joinpoint regression analysis was used to assess annual percent changes (APCs) in mortality rates. Results: PCC caused 81,793 deaths. The AAMR increased from 1999 to 2004 (APC: 5.88, 95% CI: 2.44 to 12.70), followed by a decrease from 2004 to 2014 (APC: −3.70, 95% CI: −5.83 to −2.45), and an increase again until 2020 (APC: 8.34, 95% CI: 6.05 to 11.50). Males consistently exhibited higher mortality rates (AAMR: 11.08, 95% CI: 11.00 to 11.6) than females (AAMR: 8.34, 95% CI: 8.26 to 8.43). Racial/ethnic disparities were evident, with American Indian or Alaskan natives showing the highest AAMR (19.76) compared to Asian or Pacific Islanders (6.11). Geographic disparities were observed, with the Midwest region (AAMR: 12.86) and West Virginia (AAMR: 18.52) exhibiting significantly higher mortality rates. Conclusion: Mortality trends associated with PCC in T2DM patients have shown complex trajectories, with notable disparities across demographic and geographic lines. Further research is needed to comprehensively understand the dynamics of PCC and its implications for public health.

17 July 2026 in Medicine
Verified
Journal Article
Open access
MAMuhammad Tanveer Alam
Muhammad Tanveer Alam
SKSyed Muhammad Kashif
Syed Muhammad Kashif
MLMuhammad Luqman
Muhammad Luqman
SRSandesh Raja
Sandesh Raja
ABAfeera Bashir
Afeera Bashir
ACAayush Chaulagain
Aayush Chaulagain
Rationale: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, potentially life-threatening hypersensitivity reaction. Its occurrence during pregnancy, especially secondary to anti-tuberculous therapy (ATT), is exceedingly uncommon and presents major diagnostic and therapeutic challenges. Patient concerns: A 23-year-old pregnant woman (14 weeks gestation) presented with prolonged fever, jaundice, rash with desquamation, and respiratory symptoms while on first-line ATT for pulmonary tuberculosis. Diagnoses: Laboratory evaluation revealed severe eosinophilia, deranged liver function, hepatitis E virus co-infection, and autoimmune overlap (systemic lupus erythematosus with antiphospholipid antibody positivity). Based on clinical features and a Registry of Severe Cutaneous Adverse Reactions score of 6, a definite diagnosis of DRESS syndrome was established. Interventions: ATT was discontinued, and she was treated with systemic corticosteroids, antihistamines, and topical therapy. Sequential drug challenges confirmed hypersensitivity to all 4 first-line agents, necessitating initiation of bedaquiline, clofazimine, and delamanid. Outcomes: The patient showed favorable clinical recovery with improvement in systemic manifestations and stabilization of pregnancy. She was discharged on modified ATT with multidisciplinary follow-up. Lessons: This case highlights the complexity of diagnosing and managing DRESS in pregnancy, particularly in tuberculosis-endemic regions. Coexisting viral hepatitis and autoimmune disorders may mimic or exacerbate the syndrome, underlining the importance of high clinical suspicion, timely drug withdrawal, and individualized therapy.